6533b831fe1ef96bd12994e8
RESEARCH PRODUCT
A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates
V. M. StoneM. M. HankaniemiO. H. LaitinenA. B. Sioofy-khojineA. LinI. M. Diaz LozanoM. A. MazurV. MarjomäkiK. LoréH. HyötyV. P. HytönenM. Flodström-tullbergsubject
PrimatesImmunologynuoruustyypin diabetesrokotteetvasta-aineetSciAdv r-articlesCoxsackievirus Infectionscomplex mixturesEnterovirus B HumanenteroviruksetMiceMyocarditisVirologyAnimalsimmuniteettiHealth and MedicineVaccines Combinedkoe-eläinmallitResearch ArticlesResearch Articledescription
A proof-of-concept study shows the generation of an immunogenic hexavalent Coxsackie B virus vaccine that prevents disease.
year | journal | country | edition | language |
---|---|---|---|---|
2020-05-01 |